Market revenue in 2023 | USD 197.8 million |
Market revenue in 2030 | USD 277.0 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.79% in 2023. Horizon Databook has segmented the Egypt formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Egypt's formulation development outsourcing market is expanding steadily due to a favorable business climate and a trained workforce base. Global pharmaceutical companies aiming to expand their operations in the region found the country to be an appealing option due to its advantageous location between Europe and Africa.
In addition, the government has been actively pushing the development of the pharmaceutical sector by launching numerous projects and giving a variety of incentives to draw in international investment. Despite Egypt's comparatively low research investment compared to other MEA nations, the country's large population and high disease burden are projected to encourage drug discovery efforts and support the expansion of the formulation development outsourcing business.
Horizon Databook provides a detailed overview of country-level data and insights on the Egypt formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Egypt formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account